Christian BRESSY


En résumé

I have a background in cellular and molecular biology, biochemistry, pharmacology, oncology and virology. During my PhD in the lab UMR8203 at Institute Gustave Roussy (Villejuif), I worked about different treatments to fight cancer, notably with chemotherapies and oncolytic viruses (adenovirus). More specially, I combined an oncolytic adenovirus with Histone deacetylase inhibitors (epigenetic drugs) to improve anti-tumor effects in Vitro and in Vivo on different kidney and colon cancer cells. Then I performed a post-doctoral position at Inserm U1068 (Marseille) to better understand the molecular mechanisms of some cancers like the pancreatic cancer and its microenvironment. Then I moved in USA (Charlotte NC), in a lab from UNCC where I performed a second post-doctoral position about the treatment of pancreatic cancer cells with an oncolytic agent based on vesicular stomatitis virus (VSV). Now (since July 2018), I am working at University of Pennsylvania (Upenn) about immunotherapy strategy based on non-viral gene therapy.

Mes compétences :
Ex Vivo Studies
Gene Expression
Quantitative PCR
Western Blotting
Adobe Illustrator
Adobe Photoshop
Microsoft Office


  • Université de Pennsylvanie - Post-doctoral scientist

    2018 - maintenant Département de Pathologie et Laboratoire de Médecine
    Université de Pennsylvanie, Philadelphie (USA)
    Nanoparticules (Liposomes), ARN interférent et immunothérapie
    Superviseur: Dr Youhai Chen
  • University of North Carolina at Charlotte (Charlotte, USA) - Post-doctoral scientist

    2016 - 2018 oncolytic virotherapy based on vesicular stomatitis virus (VSV) + chemotherapy to fight pancreatic cancer
  • INSERM U1068 Centre de Recherche en Cancérologie de Marseille (CRCM) - Post-doctoral scientist

    Marseille 2013 - 2016 Pancreatic cancer and microenvironment